Successful treatment of fulminant hepatitis B during pregnancy

Zeitschrift fur Gastroenterologie

Volumn 47, Issue 7, 2009, Pages 667-670

  Potthoff, A ^a   Rifai, K ^a   Wedemeyer, H ^a   Deterding, K ^a   Manns, M ^a   Strassburg, C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Fulminant hepatic failure; Hepatitis B; Nucleos(t)ides; Pregnancy

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; BLOOD SAMPLING; CASE REPORT; DRUG EFFICACY; FEMALE; FETUS ECHOGRAPHY; HEPATITIS B; HUMAN; INFANT; LIVER FAILURE; MECONIUM ILEUS; PREGNANCY; TREATMENT DURATION;

ANTI-HIV AGENTS; FEMALE; HEPATITIS B; HUMANS; LAMIVUDINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69549109897     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109148     Document Type: Article

References (22)

1. Shepard CW, Simard EP, Finelli L et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112-125 (Pubitemid 44289094)
2. Ayoub WS, Keeffe EB. Review article: current antiviral therapy of chronic hepatitis B. Aliment Pharmacol Ther 2008; 28: 167-177
3. Hoofnagle JH, Doo E, Liang TJ et al. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007; 45: 1056-1075 (Pubitemid 46646501)
4. Yuki N, Nagaoka T, Yamashiro M et al. Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology 2003; 37: 1172-1179 (Pubitemid 36538695)
5. Tillmann HL, Hadern J, Leifeld L et al. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 2006; 13: 256-263
6. Lee WM, Squires Jr RH, Nyberg SL et al. Acute liver failure: Summary of a workshop. Hepatology 2008; 47: 1401-1415 (Pubitemid 351547926)
7. Acharya SK, Dasarathy S, Kumer TL et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996; 23: 1448-1455 (Pubitemid 26181228)
8. O'Grady JG, Alexander GJ, Hayllar KM et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-445 (Pubitemid 19192181)
9. Bernuau J, Samuel D, Durand F et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal. Hepatology 1991; 14: 49A
10. Miyake Y, Iwasaki Y, Takaki A et al. Lamivudine treatment improves the prognosis of fulminant hepatitis B. Intern Med 2008; 47: 1293-1299
11. Miyake Y, Iwasaki Y, Terada R et al. Systemic inflammatory response syndrome strongly affects the prognosis of patients with fulminant hepatitis B. J Gastroenterol 2007; 42: 485-492 (Pubitemid 47050012)
12. Cornberg M, Protzer U, Dollinger MM et al. Prophylaxe, Diagnose und Therapie der Hepatitis-B-Virus-(HBV-) Infektion. Z Gastroenterol 2007; 45: 1-50
13. Li XM, Ma L, Yang YB et al. Clinical characteristics of fulminant hepatitis in pregnancy. World J Gastroenterol 2005; 11: 4600-4603 (Pubitemid 41150408)
14. Hung JH, Chu CJ, Sung PL et al. Lamivudine therapy in the treatment of chronic hepatitis B with acute exacerbation during pregnancy. J Chin Med Assoc 2008; 71: 155-158 (Pubitemid 351618661)
15. Su GG, Pan KH, Zhao NF et al. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004; 10: 910-912 (Pubitemid 38418373)
16. van Zonneveld M, van Nunen AB, Niesters HG et al. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003; 10: 294-297
17. Roussos A, Koilakou S, Kalafatas I et al. Lamivudine treatment for acute severe hepatitis B: report of a case and review of the literature. Acta Gastroenterol Belg 2008; 71: 30-32 (Pubitemid 351613483)
18. Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India. J Viral Hepat 2003; 10: 224-231 (Pubitemid 36629672)
19. Sookoian S. Liver disease during pregnancy: acute viral hepatitis. Ann Hepatol 2006; 5: 231-236 (Pubitemid 44444600)
20. Schroter B, Chaoui R, Meisel H et al. Maternal hepatitis B infection as the cause of nonimmunologic hydrops fetalis. Z Geburtshilfe Neonatol 1999; 203: 36-38
21. Nigro G, La Torre R, Mazzocco M et al. Multi-system cytomegalovirus fetopathy by recurrent infection in a pregnant woman with hepatitis B. Prenat Diagn 1999; 19: 1070-1072
22. Su WH, Wang PH, Yuan CC et al. Fetal meconium peritonitis in the infant of a woman with fulminant hepatitis B. A case report. J Reprod Med 2002; 47: 952-954